Galapagos NV (MEX:GLPG)
MXN 665.65 0 (0%) Market Cap: 36.46 Bil Enterprise Value: -33.70 Bil PE Ratio: 8.38 PB Ratio: 0.60 GF Score: 55/100

Galapagos NV at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 06:30PM GMT
James Patrick Quigley
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everybody. I'm James Quigley, European pharma & biotech analyst at JPMorgan, and it's my pleasure to welcome you all to the Galapagos presentation. With us today is the COO and CFO, Bart Filius. After Bart's presentation, there will be a breakout in the Yorkshire room, which is just on -- as you come out of the doors, to our left.

So with that, over to you, Bart.

Bart Filius
Galapagos NV - CFO & COO

Thank you very much, James, and thanks for having me here at the conference, and a warm welcome this morning to everyone here in the U.S. and also to those that are listening in to the live stream through Internet and especially also our friends, investors and colleagues from Europe that are participating.

So I'm really happy to be here and to get a chance for about half an hour to present the highlights on Galapagos. After a special year 2019, I can say, we're up to a very interesting and very exciting year 2020 as well.

So let me take

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot